학술논문
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial
Document Type
Article
Author
Krop, Ian E; Mayer, Ingrid A; Ganju, Vinod; Dickler, Maura; Johnston, Stephen; Morales, Serafin; Yardley, Denise A; Melichar, Bohuslav; Forero-Torres, Andres; Lee, Soo Chin; de Boer, Richard; Petrakova, Katarina; Vallentin, Susanne; Perez, Edith A; Piccart, Martine; Ellis, Matthew; Winer, Eric; Gendreau, Steven; Derynck, Mika; Lackner, Mark; Levy, Gallia; Qiu, Jiaheng; He, Jing; Schmid, Peter
Source
In The Lancet Oncology June 2016 17(6):811-821
Subject
Language
ISSN
1470-2045